Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
PreprintCC BYbioRxiv

Function-oriented microglial transcriptional scores in Alz-heimer's disease: resolving terminal functions beyond activa-tion states

  1. 1Beijing Institute of Technology

Abstract

Alzheimer's disease (AD) staging based on amyloid-{beta}, tau, and neurodegeneration does not capture heterogeneous microglial functions. Existing transcriptomic scores indicate microglial activation or state similarity but do not resolve post-activation functions and are not directly comparable across scales. Herein, we develop a function-oriented framework comprising seven harmful-and seven adaptive-associated gene modules, selected from predefined mechanisms and direct functional evidence. Using SEA-AD micro-glia/perivascular macrophage nuclei, we compute do-nor-brain-region pseudobulk scores on a fixed P10-P90 reference scale and validate them against matched protein, activity, and tissue endpoints. H3 is related to cytokine/chemokine proteins; H4 and A5 are related to the same isoprostane readout in opposite directions; and A3 is related to dense-core plaque fraction. Benchmark comparison shows modest incremental fit but distinct out-come-specific information. In external GSE146639, eight modules remained FDR-significant, although harmful and adaptive arms are highly collinear; H7 and A2 are replicated in external proteomics. Downsampling, leave-one-gene-out, and alternative scoring analyses supports technical stability, and single-cell reconstruction supported a state-resolved basis. These scores summarize relative engagement of damage-related and adaptive programmes, enabling mechanistic comparison across donors and brain regions, but remain observational, are not intended for clinical decision-making, and require further validation.

Related

  1. A synthetic PGC1α co-activator reprograms microglial immunometabolism to preserve cone function in retinal degeneration
    T. Winogrodzki, J. Hernandez-Reyes, R. Solanky +17
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  2. NR2F6 functions as a key transcriptional checkpoint enforcing dysfunction of human CD3+ T cells and limiting CAR-T cell potency
    Jiří Koutník, Thomas Gruber, Dorothee Freimark +11
    iSciencePeer-reviewedCC BY 4.0Cell biologyImmunologyCell PressCrossref
  3. Astrocytic sEH-EET signaling regulates microglial lysosomal function and suppresses the STING-Type I interferon pathway in Alzheimer's disease
    B. Ghosh, S. Wang, C. Qi +5
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  4. Cis-Attenuation of Pathogenic Scn8a Variant Causing Childhood Epilepsy Reveals Opposing Transcriptional Programs Driving NaV1.6 Gain and Loss of Function Phenotypes
    M. F. Hammer, E. Bahramnejad
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  5. CDC5L functions as a transcriptional repressor to safeguard against overactive stress response and promote survival.
    Shunyi Li, Beituo Qian, Feng Qiu +5
    Genome biologyPeer-reviewedCC BY-NC-NDFull textCell biologyEurope PMCPMC
BibTeX
@misc{tu2026functionoriented,
  title = {{Function-oriented microglial transcriptional scores in Alz-heimer's disease: resolving terminal functions beyond activa-tion states}},
  author = {A. Tu and S. Liu},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.14.759278},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.14.759278v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Function-oriented microglial transcriptional scores in Alz-heimer's disease: resolving terminal functions beyond activa-tion states
AU  - A. Tu
AU  - S. Liu
PY  - 2026
DA  - 2026/10/14
PB  - bioRxiv
DO  - 10.64898/2026.10.14.759278
UR  - https://www.biorxiv.org/content/10.64898/2026.10.14.759278v1
AB  - Alzheimer's disease (AD) staging based on amyloid-{beta}, tau, and neurodegeneration does not capture heterogeneous microglial functions. Existing transcriptomic scores indicate microglial activation or state similarity but do not resolve post-activation functions and are not directly comparable across scales. Herein, we develop a function-oriented framework comprising seven harmful-and seven adaptive-associated gene modules, selected from predefined mechanisms and direct functional evidence. Using SEA-AD micro-glia/perivascular macrophage nuclei, we compute do-nor-brain-region pseudobulk scores on a fixed P10-P90 reference scale and validate them against matched protein, activity, and tissue endpoints. H3 is related to cytokine/chemokine proteins; H4 and A5 are related to the same isoprostane readout in opposite directions; and A3 is related to dense-core plaque fraction. Benchmark comparison shows modest incremental fit but distinct out-come-specific information. In external GSE146639, eight modules remained FDR-significant, although harmful and adaptive arms are highly collinear; H7 and A2 are replicated in external proteomics. Downsampling, leave-one-gene-out, and alternative scoring analyses supports technical stability, and single-cell reconstruction supported a state-resolved basis. These scores summarize relative engagement of damage-related and adaptive programmes, enabling mechanistic comparison across donors and brain regions, but remain observational, are not intended for clinical decision-making, and require further validation.
ER  -